AMEREN CORP

For the period ended Sep 30, 2025. Filed Nov 6, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 6, 2025

AEE$114.02+1.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheet

	September 30,2025	December 31, 2024
ASSETS
Current Assets:
Cash and cash equivalents	$9	$7
Accounts receivable – trade (less allowance for doubtful accounts of $38 and $30, respectively)	794	525
Unbilled revenue	413	346
Miscellaneous accounts receivable	78	96
Inventories	804	762
Current regulatory assets	260	366
Other current assets (includes $46 and $2 related to VIEs, respectively)	252	162
Total current assets	2,610	2,264
Property, Plant, and Equipment, Net	38,411	36,304
Investments and Other Assets:
Nuclear decommissioning trust fund	1,502	1,342
Goodwill	411	411
Regulatory assets (includes $449 and $465 related to VIEs, respectively)	2,611	2,397
Pension and other postretirement benefits	741	757
Other assets	1,130	1,123
Total investments and other assets	6,395	6,030
TOTAL ASSETS	$47,416	$44,598
LIABILITIES AND EQUITY
Current Liabilities:
Current maturities of long-term debt (includes $29 and $17 related to VIEs, respectively)	$29	$317
Short-term debt	903	1,143
Accounts and wages payable	762	1,059
Taxes accrued	215	60
Interest accrued	183	196
Customer deposits	248	223
Current regulatory liabilities	142	120
Other current liabilities	323	295
Total current liabilities	2,805	3,413
Long-term Debt, Net (includes $437 and $448 related to VIEs, respectively)	19,172	17,262
Deferred Credits and Other Liabilities:
Accumulated deferred income taxes and tax credits, net	5,081	4,474
Regulatory liabilities	6,089	5,897
Asset retirement obligations	844	822
Other deferred credits and liabilities	516	487
Total deferred credits and other liabilities	12,530	11,680
Commitments and Contingencies (Notes 2, 9, and 10)
Shareholders’ Equity:
Common stock, $.01 par value, 400.0 shares authorized – shares outstanding of 270.5 and 269.9, respectively	3	3
Other paid-in capital, principally premium on common stock	7,559	7,513
Retained earnings	5,232	4,604
Accumulated other comprehensive loss	(14)	(6)
Total shareholders’ equity	12,780	12,114
Noncontrolling Interests	129	129
Total equity	12,909	12,243
TOTAL LIABILITIES AND EQUITY	$47,416	$44,598

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.